Table 2.
Clinical characteristics of the study tumor samples
| Characteristic | Status | IBC (%) | CIS (%) |
|---|---|---|---|
| Tumor size | pT1 | 13.3 | |
| pT2 | 65.3 | ||
| pT3 | 19.4 | ||
| pT4 | 1.0 | ||
| No report | 1.0 | ||
| Lymph node status | pN0 | 44.9 | |
| pN1 | 20.4 | ||
| pN2 | 19.4 | ||
| pN3 | 8.2 | ||
| pNx | 6.1 | ||
| No report | 1.0 | ||
| Grade (Nottingham score) | I | 2.0 | 4.2 |
| II | 38.8 | 43.7 | |
| III | 46.9 | 38.0 | |
| No report | 12.2 | 14.1 | |
| Estrogen Receptor | Negative | 33.7 | 32.4 |
| Positive | 65.3 | 67.6 | |
| No report | 1.0 | 0.0 | |
| Progesterone Receptor | Negative | 43.9 | 39.4 |
| Positive | 55.1 | 60.6 | |
| No report | 1.0 | 0 | |
| HER2/ErbB2/neu | Negative/ Equivocal | 81.6 | 69.0 |
| Positive | 17.3 | 21.1 | |
| No report | 1.0 | 9.9 |